following details. Financial performance Statement of income Consolidated financial statements for the year 2018 2017 Change (Audited) (Audited/Restated) Increase (Decrease) THB Million % THB Million % THB

quarter of 2017. A summary of the Company’s operating performance in the second quarter of 2018 and 2017 is shown in the following table: 2Q18 1Q18 % Change 2Q17 % Change [Amount in Baht Million] Q-o-Q Y-o

its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2018 - June 2018 Apr 2017 - June 2017 Change % Change Revenue

changes are explained as follows; Sales Revenues: For the year of 2017, the Company generated a revenue from sales of 167.41 million Baht, increasing by 27.39% from the previous year, which had a total

Increase (Decrease) % Change Sales income 15,400.82 15,097.66 303.16 2.01% Rental and service income 493.36 480.81 12.55 2.61% Other income 599.77 577.93 21.84 3.78% Total revenues 16,493.95 16,156.40 337.56

(Translation) Re: BOD.SET 003/2020 February 25, 2020 Subject: Clarification on the Change in operating results for the twelve month ended 31 December 2019 over 20% compared with the same period of

period of the previous year were as highlighted below ; (Unit : Million Baht) Q3/2017 Q3/2016 % Change Sales and Service Income 514.22 465.84 +4.66 Cost of sales and Services 398.23 336.98 +3.01 Selling

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

1,699 million baht increase 20% compared with the same period last year the said collection increased from the previous quarter of 2020. In the past 6 months, the company has bought a total debt 1,983

Revenue Total revenue (core revenue and other revenue increasingly adjusted amounting . MB or . % from the previous year, which can be divided into business segments as per information in following table